A groundbreaking French multicenter study shed new light on how pregnancy affects disease activity in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). The GR2 …
A Phase 2 trial exploring the novel microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor vipoglanstat in patients with systemic sclerosis-related Raynaud’s phenomenon (RP) did not meet its primary …
A new systematic review and meta-analysis published in Medicine has highlighted the significant elevation of interleukin-18 (IL-18) in patients with primary Sjögren’s syndrome (pSS), reinforcing …
The ‘Hit Hard and Early’ randomized controlled trial published to investigate the efficacy of methylprednisolone in very early systemic sclerosis (SSc) found no significant benefit …
The long-term extension trial, contRAst X, published in BMJ Open, showed promising results regarding the safety and efficacy of otilimab, an anti-GM-CSF monoclonal antibody, in …
A recent study published in Rheumatology (Oxford) revealed a significant association between elevated plasma interferon-alpha (IFN-α) protein levels during pregnancy and lower birth weight in …
A recent Phase 3 randomized, double-blind study published in Seminars in Arthritis and Rheumatism evaluated the efficacy and safety of fasinumab, an investigational nerve growth …
Xerostomia, or dry mouth, is a significant challenge for patients with Sjögren’s syndrome, often resulting in discomfort, difficulty in speaking and swallowing, and a reduced …
A recent study published in Arthritis Research and Therapy has highlighted the emerging role of dipeptidyl peptidase-4 (DPP4) in ankylosing spondylitis (AS), revealing its potential …